Back to funds
View filing
Kalehua Capital Management LLC
hedge fundUpdated 23 days agoManaged by Kalehua Capital Management Llc • Latest filing Q2 2026
Portfolio value
$139.5M
Q2 2026
Filings
3
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 3 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $101.1M |
| Q1 2026 | $118.6M |
| Q2 2026 | $139.5M |
Top holdings
26 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | ? N/A EA SERIES TRUST | $26.5M | 226.2K | 15.22% | — |
| 2 | M MANE Veradermics Inc | $17.9M | 145.7K | 10.30% | — |
| 3 | ? N/A X4 Pharmaceuticals Inc | $17.4M | 3.72M | 9.99% | — |
| 4 | C CMPS Compass Pathways Plc | $11.6M | 819.7K | 6.67% | — |
| 5 | ? N/A Surrozen Inc | $10M | 385.2K | 5.75% | — |
| 6 | A ACRS Aclaris Therapeutics Inc | $9.7M | 1.83M | 5.57% | — |
| 7 | S SION Sionna Therapeutics Inc | $8.7M | 197.1K | 4.98% | — |
| 8 | I IKT Inhibikase Therapeutics Inc | $7.8M | 3.82M | 4.46% | — |
| 9 | P PHVS Pharvaris NV | $6.9M | 198.8K | 3.95% | — |
| 10 | K KPTI Karyopharm Therapeutics Inc | $6.7M | 685.6K | 3.85% | — |
| 11 | S SEPN Septerna Inc | $6.5M | 194.5K | 3.75% | — |
| 12 | I IFRX Inflarx Nv | $6.5M | 2.90M | 3.73% | — |
| 13 | ? N/A Cyclerion Therapeutics Inc | $5.6M | 1.65M | 3.22% | — |
| 14 | K KRRO Korro Bio Inc | $5.3M | 405.0K | 3.07% | — |
| 15 | Q QURE Uniqure Nv | $3.7M | 79.4K | 2.10% | — |
| 16 | L LONA LeonaBio Inc | $3.6M | 393.7K | 2.08% | — |
| 17 | ? N/A Damora Therapeutics Inc | $3.6M | 139.0K | 2.08% | — |
| 18 | M MLTX MoonLake Immunotherapeutics | $3.4M | 175.7K | 1.97% | — |
| 19 | A ANL Adlai Nortye | $2.6M | 226.4K | 1.50% | — |
| 20 | T TYRA Tyra Biosciences Inc | $2.4M | 74.5K | 1.37% | — |